Analyst Price Targets — TEM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 2, 2026 11:54 am | Sarah James | Raymond James | $80.00 | $62.27 | TheFly | Cantor Fitzgerald bullish on Tempus AI, initiates with an Overweight |
| September 2, 2026 10:09 am | — | Cantor Fitzgerald | $80.00 | $62.27 | TheFly | Tempus AI initiated with an Overweight at Cantor Fitzgerald |
| September 1, 2026 9:15 am | — | Piper Sandler | $76.00 | $63.05 | TheFly | Tempus AI upgraded to Overweight from Neutral at Piper Sandler |
| August 4, 2026 10:52 am | — | Piper Sandler | $56.00 | $46.05 | TheFly | Tempus AI price target lowered to $56 from $58 at Piper Sandler |
| August 3, 2026 5:54 pm | — | BTIG | $70.00 | $46.78 | TheFly | Tempus AI price target lowered to $70 from $80 at BTIG |
| August 3, 2026 5:10 pm | Yi Chen | H.C. Wainwright | $56.00 | $46.95 | TheFly | Tempus AI price target lowered to $56 from $64 at H.C. Wainwright |
| August 3, 2026 10:47 am | — | Stifel Nicolaus | $50.00 | $43.87 | TheFly | Tempus AI price target lowered to $50 from $60 at Stifel |
| July 16, 2026 10:38 am | Subbu Nambi | Guggenheim | $65.00 | $57.25 | StreetInsider | Tempus AI Inc (TEM) PT Raised to $65 at Guggenheim |
| May 11, 2026 10:19 am | Yi Chen | H.C. Wainwright | $64.00 | $49.86 | TheFly | Tempus AI price target lowered to $64 from $95 at H.C. Wainwright |
| May 10, 2026 2:07 pm | — | BTIG | $80.00 | $49.86 | TheFly | Tempus AI price target lowered to $80 from $90 at BTIG |
Latest News for TEM
The disposition involved 3,000 shares executed at $69.00 per share, totaling $207,000 in transaction value on August 28, 2026. The shares traded were equal to 9.00% of the stake held before the filing, leaving the insider with a 0.0183% ownership interest.
The biotech sector has a new catalyst beyond GLP-1 drugs. Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc's (NYSE:MRK) positive Phase 3 results for a personalized mRNA cancer vaccine could revive investor interest in genomics, immunotherapy and precision medicine ETFs.
Tempus AI (TEM) rose 2.46% premarket after Piper Sandler upgraded the stock to Overweight from Neutral and raised its price target to $76 from $56. The firm had
Wood is known for being a tech-first investor.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TEM.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.